Established in 2008, Remedia is a privately owned young pharmaceutical company engaged in cutting edge formulation research and development. We use new drug delivery systems to create medicines that offer wider choice and clear benefit to the patient. In order to reduce time to market, we develop medicines as per EU guidelines with strong regulatory focus right from project inception. Collaboration is our key strategy for R&D, and we actively license or acquire technologies and intellectual property.

Our product portfolio comprises differentiated and innovative products in our chosen focus areas of cough & cold, dermatology, musculoskeletal system, and gastroenterology. With a primarily OTC portfolio from both in house development and in-licensing, we are preparing to enter the consumer segment with branded medicines in our core markets of Russia and CIS. We are also planning to launch our products in non represented markets via reputed partners. We are headquartered in Moscow, Russia.